Prevalence of tobacco and alcohol consumption and associated factors in adults living with HIV infection
More details
Hide details
Hospital Clínico San Carlos, Madrid, Spain
Submission date: 2021-03-21
Final revision date: 2021-04-26
Acceptance date: 2021-04-27
Publication date: 2021-08-24
HIV & AIDS Review 2021;20(3):173-178
Tobacco and alcohol consumption has a significant negative impact on health of indi­viduals living with human immunodeficiency virus (HIV); however, there is little research on using these substances in this specific cohort. The objective of this study was to investigate the prevalence and factors associated with the consumption of tobacco and alcohol in adult population living with HIV as well as the clinical-epidemiological characteristics of the sample.

Material and methods:
A cross-sectional study was carried out with 381 participants diagnosed with HIV, whose information on smoking and alcohol habits, adherence to treatments, socio-demographic data, and lifestyles were collected through both electronic and printed questionnaires.

The results showed that half of the individuals were smokers, with significant percentage having a moderate or high motivation to quit smoking. Moreover, it was observed that the participants classified in the group of high alcohol consumption with AUDIT test were less adherent to pharmacological treatment. On the other hand, it should be noted that 49.3% of the sample suffered from some pathology, with cardiovascular disease being the most prevalent.

Therefore, from a clinical point of view and due to the above-mentioned reasons, it seems essential to address the consumption of tobacco and alcohol in individuals living with HIV. Along with proper health education and support offered, it can positively influence their lives in general, and at the same time, provide better HIV control.

World Health Organization. VIH/SIDA; 2018. Available from: (Accessed: 09.03.2019).
Barré-Sinoussi F, Ross AL, Delfraissy JF. Past, present and future: 30 years of HIV research. Nat Rev Microbiol 2013; 11: 277-283.
Parry CD, Morojele NK, Myers BJ, Kekwaletswe CT, Manda SO, Sorsdahl K, et al. Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treat­ment outcomes – a randomised controlled trial protocol. BMC Infect Dis 2014; 14: 500.
Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health 2010; 55: 159-166.
Kelso-Chichetto NE, Plankey M, Abraham AG, Ennis N, Chen X, Bolan R, et al. Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV. Am J Drug Alcohol Abuse 2018; 44: 85-94.
Elliott JC, Aharonovich E, Hasin DS. Reasons for limiting drinking in an HIV primary care sample. Alcohol Clin Exp Res 2014; 38: 1720-1727.
Calvo M, Laguno M, Martinez M, Martínez E. Effects of tobacco smoking on HIV-infected individuals. AIDS Rev 2014; 17: 47-55.
Calvo M, Martínez E. Riesgo cardiovascular e infección por el virus de la inmunodeficiencia humana. Enferm Infecc Microbiol Clin 2012; 30: 515-610.
Debra C, Michael BS, Polly T, Shobha S, Sally LH. Evaluation of a smoking cessation program for HIV infected individuals in an urban HIV clinic: challenges and lessons learned. AIDS Res Treat 2014; 2014: 237834.
Weinberger AH, Seng EK, Esan H, Shuter J. Perceived risks and benefits of quitting smoking in a sample of adults living with HIV/AIDS. AIDS Care 2018; 30: 564-568.
Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med 2015; 162: 335-344.
Tron L, Lert F, Spire B, Dray-Spira R; ANRS-Vespa2 study group. Tobacco smoking in HIV-infected versus general population in France: heterogeneity across the various groups of people living with HIV. PLoS One 2014; 9: e107451.
Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013; 56: 727-734.
Mdege ND, Shah S, Ayo-Yusuf OA, Hakim J, Siddiqi K. Tobacco use among people living with HIV: analysis of data from demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob Health 2017; 5: e578-e592.
Jin ZY, Liu X, Ding YY, Zhang ZF, He N. Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysis. Sci Rep 2017; 7: 4890.
Nguyen NP, Tran BX, Hwang LY, Markham CM, Swartz MD, Phan HTT, et al. Prevalence of cigarette smoking and associated factors in a large sample of HIV-positive patients receiving antiretroviral therapy in Vietnam. PLoS One 2015; 10: e0118185.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88: 791-804.
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT Alcohol Consumption Questions (AUDIT-C): an effec­tive brief screening test for problem drinking. Arch Intern Med 1998; 158: 1789-1795.
Richmond RL, Kehoe LA, Webster IW. Multivariate models for predicting abstention following. Addiction 1993; 88: 1127-1135.
INE2019. Encuesta nacional de salud 2017. Madrid: Instituto Nacional de Estadística [Online]. Available from:
125473617678 3&menu=resultados&secc=1254736195650&idp=1254735573175.
Shuter J, Pearlman BK, Stanton CA, Moadel AB, Kim RS, Weinberger AH. Gender differences among smokers living with HIV. J Int Assoc Provid AIDS Care 2016; 15: 412-417.
Brown JL, DeMartini KS, Sales JM, Swartzendruber AL, DiCle­mente RJ. Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature. Curr HIV/AIDS Rep 2013; 10: 356-370.
Journals System - logo
Scroll to top